BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,070 filers reported holding BAXTER INTL INC in Q3 2021. The put-call ratio across all filers is 0.84 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $27,688,034 | +52.7% | 733,652 | +84.4% | 0.01% | +62.5% |
| Q2 2023 | $18,129,826 | +18.1% | 397,933 | +5.2% | 0.01% | +14.3% |
| Q1 2023 | $15,346,055 | -18.4% | 378,354 | +2.6% | 0.01% | -30.0% |
| Q4 2022 | $18,801,216 | +67.2% | 368,868 | +76.7% | 0.01% | +66.7% |
| Q3 2022 | $11,244,000 | -8.2% | 208,760 | +9.4% | 0.01% | -14.3% |
| Q2 2022 | $12,254,000 | -22.8% | 190,788 | -6.8% | 0.01% | -12.5% |
| Q1 2022 | $15,870,000 | -11.9% | 204,668 | -2.5% | 0.01% | -11.1% |
| Q4 2021 | $18,013,000 | +35.5% | 209,846 | +27.0% | 0.01% | +28.6% |
| Q3 2021 | $13,290,000 | +17.1% | 165,234 | +17.2% | 0.01% | +16.7% |
| Q2 2021 | $11,349,000 | -1.0% | 140,980 | +3.7% | 0.01% | -14.3% |
| Q1 2021 | $11,466,000 | +35.5% | 135,947 | +29.0% | 0.01% | +16.7% |
| Q4 2020 | $8,459,000 | -10.8% | 105,425 | -10.6% | 0.01% | -25.0% |
| Q3 2020 | $9,484,000 | -7.1% | 117,929 | -0.5% | 0.01% | -20.0% |
| Q2 2020 | $10,205,000 | -12.5% | 118,525 | -17.5% | 0.01% | -28.6% |
| Q1 2020 | $11,663,000 | -48.1% | 143,651 | -46.6% | 0.01% | -41.7% |
| Q4 2019 | $22,490,000 | -6.5% | 268,958 | -2.2% | 0.02% | -7.7% |
| Q3 2019 | $24,049,000 | -2.2% | 274,938 | -8.5% | 0.03% | -16.1% |
| Q2 2019 | $24,601,000 | -3.4% | 300,375 | -4.1% | 0.03% | -11.4% |
| Q1 2019 | $25,458,000 | +8.4% | 313,093 | -12.2% | 0.04% | -2.8% |
| Q4 2018 | $23,482,000 | +4056.1% | 356,761 | +4769.8% | 0.04% | +3500.0% |
| Q3 2018 | $565,000 | -94.7% | 7,326 | -94.9% | 0.00% | -95.8% |
| Q2 2018 | $10,632,000 | +11.3% | 143,967 | -0.6% | 0.02% | -11.1% |
| Q1 2018 | $9,556,000 | -37.4% | 144,779 | -38.7% | 0.03% | -20.6% |
| Q4 2017 | $15,271,000 | +30.1% | 236,217 | +26.3% | 0.03% | +21.4% |
| Q3 2017 | $11,740,000 | -30.4% | 187,045 | -32.9% | 0.03% | -40.4% |
| Q2 2017 | $16,874,000 | +21.1% | 278,722 | +3.7% | 0.05% | +4.4% |
| Q1 2017 | $13,939,000 | +18.1% | 268,759 | +1.0% | 0.04% | +4.7% |
| Q4 2016 | $11,798,000 | +29.3% | 266,195 | +38.8% | 0.04% | +22.9% |
| Q3 2016 | $9,127,000 | +6.5% | 191,748 | +1.2% | 0.04% | +2.9% |
| Q2 2016 | $8,570,000 | -5.9% | 189,511 | -14.6% | 0.03% | -12.8% |
| Q1 2016 | $9,112,000 | +4.2% | 221,806 | -3.2% | 0.04% | -2.5% |
| Q4 2015 | $8,745,000 | +47.8% | 229,218 | +27.2% | 0.04% | +37.9% |
| Q3 2015 | $5,918,000 | -60.9% | 180,160 | -16.7% | 0.03% | -59.7% |
| Q2 2015 | $15,129,000 | -39.1% | 216,345 | -40.3% | 0.07% | -43.8% |
| Q1 2015 | $24,832,000 | +3320.4% | 362,515 | +3557.3% | 0.13% | +1728.6% |
| Q4 2014 | $726,000 | -53.9% | 9,912 | -54.8% | 0.01% | -56.2% |
| Q3 2014 | $1,574,000 | +29.0% | 21,934 | +30.0% | 0.02% | +23.1% |
| Q2 2014 | $1,220,000 | +24.7% | 16,874 | +26.9% | 0.01% | +18.2% |
| Q1 2014 | $978,000 | +32.7% | 13,296 | +25.5% | 0.01% | +37.5% |
| Q4 2013 | $737,000 | -20.3% | 10,592 | -24.8% | 0.01% | -27.3% |
| Q3 2013 | $925,000 | -9.4% | 14,085 | -4.5% | 0.01% | -15.4% |
| Q2 2013 | $1,021,000 | – | 14,744 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |